The landscape included PI3K/AKT/mTOR pathways-related genes, tumor suppressor genes, cell cycle genes, etc. This evidenced that multiple mechanisms contribute to the genesis and development of glioma, many of them are potential targets of precision therapies (Table 2). This evidence concerns the gene PIK3CA and central nervous system cancer.